Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed details of the Analyst/ Institutional Investor Meeting with the Company to be held on 21st March 2023 with Ashmore Investments as One on One -In-person meeting.
The above information is a part of company’s filings submitted to BSE.